Table_2.xls (5.5 kB)
Evaluation of combination agents in CD-DST.
dataset
posted on 2013-08-28, 01:40 authored by Katsushi Takebayashi, Eiji Mekata, Hiromichi Sonoda, Tomoharu Shimizu, Hisanori Shiomi, Shigeyuki Naka, Yoshihiro Endo, Tohru TaniThe in vitro sensitivity was expressed as the T/C ratio, in which T is the total volume of living cancer cells in the treated group, and C is the total volume of living cancer cells in the control group. Positive, T/C <60%; negative, T/C ≥ 60%.
5-FU, 5-fluorouracil; SN38, the active metabolite of irinotecan; OHP, the active metabolite of oxaliplatin.
*statistically significant.